Hideyuki Tsukitome
Overview
Explore the profile of Hideyuki Tsukitome including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
70
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tomioka M, Murakami T, Okamoto F, Kinoshita T, Shinomiya K, Nishi T, et al.
Retina
. 2023 Dec;
44(4):652-658.
PMID: 38064668
Purpose: To investigate the 5-year treatment outcomes of retinopathy of prematurity in infants <500 g birth weight and compare laser and anti-vascular endothelial growth factor therapies. Methods: A multicenter retrospective...
2.
Murakami T, Okamoto F, Kinoshita T, Shinomiya K, Nishi T, Obata S, et al.
Eye (Lond)
. 2023 May;
37(17):3589-3595.
PMID: 37149685
Objectives: To compare real-world, long-term outcomes of laser and anti-vascular endothelial growth factor (VEGF) therapies in patients with retinopathy of prematurity (ROP). Methods: This was a multicentre retrospective study. We...
3.
Kato K, Nagashima R, Matsubara H, Ikesugi K, Tsukitome H, Matsui Y, et al.
Ophthalmol Sci
. 2022 Dec;
3(1):100243.
PMID: 36545261
Purpose: To determine the characteristics and cause of the increase in the amplitude of flicker electroretinography (ERG) after cataract surgery. Design: Prospective, observational clinical study. Participants: Thirty patients who underwent...
4.
Maeda S, Sugimoto M, Tenma Y, Tsukitome H, Kato K, Chujo S, et al.
J Clin Med
. 2022 Nov;
11(21).
PMID: 36362644
Purpose: To determine whether the response to the initial anti-vascular endothelial growth factor (anti-VEGF) injection to treat diabetic macular edema (DME) is significantly correlated with the response to the third...
5.
Asami S, Sugimoto M, Tsukitome H, Kato K, Matsubara H, Kondo M
Clin Ophthalmol
. 2022 Jul;
16:2275-2283.
PMID: 35872969
Purpose: To compare the therapeutic effects of anti-vascular endothelial growth factor (anti-VEGF) agents in eyes with macular edema associated with branch retinal vein occlusion (BRVO-ME) with glaucoma to those without...
6.
Sugimoto M, Sampa K, Tsukitome H, Kato K, Matsubara H, Asami S, et al.
J Clin Med
. 2022 May;
11(10).
PMID: 35629076
In the original publication [...].
7.
Sugimoto M, Sampa K, Tsukitome H, Kato K, Matsubara H, Asami S, et al.
J Clin Med
. 2022 Jan;
11(1).
PMID: 35011906
The aim of this study was to determine the prevalence and progression of diabetic retinopathy (DR) with hyperglycemic disorders during pregnancy (HDPs) in Japan between 2013 and 2018 using two...
8.
Sugimoto M, Tsukitome H, Okamoto F, Oshika T, Ueda T, Niki M, et al.
J Diabetes Investig
. 2018 Sep;
10(2):475-483.
PMID: 30204303
Aims/introduction: To determine the current clinical preferences of anti-vascular endothelial growth factor (VEGF) treatment protocols for diabetic macular edema (DME) in Japan. Materials And Methods: This was a descriptive cross-sectional...
9.
Ikesugi K, Ichio T, Tsukitome H, Kondo M
Jpn J Ophthalmol
. 2017 Apr;
61(4):293-298.
PMID: 28447270
Purpose: To determine the annual incidence of visual impairment in a Japanese population during a 10-year period. Methods: We examined the physical disability certificates issued yearly between 2004 and 2013...
10.
Matsubara H, Miyata R, Kobayashi M, Tsukitome H, Ikesugi K, Kondo M
Case Rep Ophthalmol
. 2016 Jul;
7(1):230-6.
PMID: 27462248
Intravitreal injections of anti-vascular endothelial growth factor (VEGF) agents are widely used to treat neovascular age-related macular degeneration (nAMD). Although these treatments are effective, multiple injections have recently been recommended...